[HTML][HTML] Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis
L Mollica, C Leli, S Puglisi, S Sardi, F Sottotetti - Drugs in Context, 2021 - ncbi.nlm.nih.gov
Leptomeningeal carcinomatosis (LC) is a rare but challenging manifestation of advanced
breast cancer with a severe impact on morbidity and mortality. We performed a systematic …
breast cancer with a severe impact on morbidity and mortality. We performed a systematic …
Stereotactic radiosurgery as treatment for brain metastases: an update
I Peña-Pino, CC Chen - Asian journal of neurosurgery, 2023 - thieme-connect.com
Stereotactic radiosurgery (SRS) is a mainstay treatment option for brain metastasis (BM).
While guidelines for SRS use have been outlined by professional societies, consideration of …
While guidelines for SRS use have been outlined by professional societies, consideration of …
Leptomeningeal disease in neurosurgical brain metastases patients: a systematic review and meta-analysis
IA Tewarie, CAC Jessurun… - Neuro-Oncology …, 2021 - academic.oup.com
Background Leptomeningeal disease (LMD) is a complication distinguished by progression
of metastatic disease into the leptomeninges and subsequent spread via cerebrospinal fluid …
of metastatic disease into the leptomeninges and subsequent spread via cerebrospinal fluid …
Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2+ Breast Leptomeningeal Carcinomatosis Growth via Inhibition of GMCSF Expression
A Bhan, KI Ansari, MY Chen, R Jandial - Cancer research, 2021 - AACR
HER2+ breast leptomeningeal carcinomatosis (HER2+ LC) occurs when tumor cells spread
to cerebrospinal fluid–containing leptomeninges surrounding the brain and spinal cord, a …
to cerebrospinal fluid–containing leptomeninges surrounding the brain and spinal cord, a …
Leptomeningeal metastasis in ER+ HER2-advanced breast cancer patients: a review of the cases in a single institute over a 15-year period
J Watanabe, K Mitsuya, S Nakamoto, H Harada… - Breast Cancer Research …, 2021 - Springer
Purpose While leptomeningeal metastasis (LM) from estrogen receptor-positive, HER2-
negative advanced breast cancer (ER+ HER2-ABC) has a poor prognosis, the details of …
negative advanced breast cancer (ER+ HER2-ABC) has a poor prognosis, the details of …
[HTML][HTML] Outcomes in patients with intact and resected brain metastasis treated with 5-fraction stereotactic radiosurgery
DJ Carpenter, AT Fairchild, JD Adamson… - Advances in Radiation …, 2023 - Elsevier
Purpose Hypofractionated stereotactic radiosurgery (HF-SRS) with or without surgical
resection is potentially a preferred treatment for larger or symptomatic brain metastases …
resection is potentially a preferred treatment for larger or symptomatic brain metastases …
What if: A retrospective reconstruction of resection cavity stereotactic radiosurgery to mimic neoadjuvant stereotactic radiosurgery
G Acker, M Nachbar, N Soffried, B Bodnar… - Frontiers in …, 2023 - frontiersin.org
Introduction Neoadjuvant stereotactic radiosurgery (NaSRS) of brain metastases has gained
importance, but it is not routinely performed. While awaiting the results of prospective …
importance, but it is not routinely performed. While awaiting the results of prospective …
Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is currently the leading cause of cancer-related death
worldwide, and the incidence of brain metastases (BM) in NSCLC patients is continuously …
worldwide, and the incidence of brain metastases (BM) in NSCLC patients is continuously …
Radiotherapy for leptomeningeal carcinomatosis in breast cancer patients: A narrative review
E Pawłowska, A Romanowska, J Jassem - Cancers, 2022 - mdpi.com
Simple Summary Leptomeningeal carcinomatosis (LC) is a rare event in breast cancer (BC)
patients that carries an abysmal prognosis. Little progress has been made in this field in the …
patients that carries an abysmal prognosis. Little progress has been made in this field in the …
[HTML][HTML] Surgery for Control of Brain Metastases After Previous Checkpoint Inhibitor Immunotherapy
Background Despite reports on the efficacy of checkpoint inhibitor (CPI) immunotherapies
for metastatic cancers, there are limited data on the effectiveness of surgery for brain …
for metastatic cancers, there are limited data on the effectiveness of surgery for brain …